Detalhe da pesquisa
1.
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
J Hepatol
; 78(3): 627-642, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36462680
2.
DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2.
Cell Oncol (Dordr)
; 45(6): 1187-1202, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327092